TADALAFIL USP: recall status

⚠ Recalls found. TADALAFIL USP is named in 3 official recalls in our current data:

FDA Class II recall D-0760-2026 — CGMP Deviations:Noted during FDA inspection
FDA Class II recall D-0761-2026 — CGMP Deviations:Noted during FDA inspection
FDA Class II recall D-0762-2026 — CGMP Deviations:Noted during FDA inspection

Brand: Shoolin Pharma Chem LLP

Recalls naming this model

FDA Class II · Drug · August 19, 2026

TADALAFIL USP recall — Shoolin Pharma Chem LLP

CGMP Deviations:Noted during FDA inspection

Company / brand: Shoolin Pharma Chem LLP recalls

Affected product: TADALAFIL USP recall status

Official ID D-0760-2026 · Official record ↗

FDA Class II · Drug · August 19, 2026

TADALAFIL USP recall — Shoolin Pharma Chem LLP

CGMP Deviations:Noted during FDA inspection

Company / brand: Shoolin Pharma Chem LLP recalls

Affected product: TADALAFIL USP recall status

Official ID D-0761-2026 · Official record ↗

FDA Class II · Drug · August 19, 2026

TADALAFIL USP recall — Shoolin Pharma Chem LLP

CGMP Deviations:Noted during FDA inspection

Company / brand: Shoolin Pharma Chem LLP recalls

Affected product: TADALAFIL USP recall status

Official ID D-0762-2026 · Official record ↗

See all Shoolin Pharma Chem LLP recalls →

Verify with the official sources:

CPSC — consumer products ↗ (aggregated here)
NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
FDA — food, drugs, medical devices ↗ (aggregated here)
USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
Recalls.gov — the U.S. government’s all-agency portal ↗

Found something wrong or missing? Report a data error.

Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 6:00 PM UTC.